Back

Colchicine prevents post-ablation atrial fibrillation recurrence: a systematic review and meta-analysis

31 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Prognostic factors on outcome after catheter ablation for atrial fibrillation Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hritvik Jain

All India Institute of Medical Sciences, Jodhpur (India)

7 More presentations in this session

Presentation thumbnail
Strategic timing- early and delayed catheter ablation in atrial fibrillation
Mr O. Makdah (Senftenberg, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation ablation with temperature-controlled very high-power short-duration, with conventional-power, or with combined modes in clinical practice: 12-month outcomes from SECURE
Doctor M. Grimaldi (Acquaviva Delle Fonti, IT)
Abstract Slides Video
Presentation thumbnail
Elucidating the mechanism of rapid functional recovery following atrial fibrillation ablation in patients with left ventricular systolic dysfunction
Doctor M. Okada (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
LA strain analysis in patients undergoing atrial fibrillation ablation using cryoballoon or pulsed-field-ablation
Mr C. Eitel (Kuenzell, DE)
Abstract Slides Video
Presentation thumbnail
Long-term efficacy of concomitant surgical ablation for atrial fibrillation with cardiac surgery
Doctor J. Lee (Sheffield, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostic factors on outcome after catheter ablation for atrial fibrillation

The Event

Event poster

ESC Congress 2024

31 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of colchicine on atrial fibrillation recurrence following pulmonary vein isolation
thumbnail
Congress Presentation
Colchicine for prevention of pericarditis after catheter ablation: A systematic review and meta-analysis.
thumbnail
Congress Presentation
Can colchicine tame atrial fibrillation? A scoping review

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources